BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20287850)

  • 1. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 2. British anti-lewisite; arsenic and thiol excretion in animals after treatment of lewisite burns.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):548-54. PubMed ID: 20273640
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 4. British anti-lewisite (BAL), the classic heavy metal antidote.
    Oehme FW
    Clin Toxicol; 1972; 5(2):215-22. PubMed ID: 4559017
    [No Abstract]   [Full Text] [Related]  

  • 5. BAL (British anti-lewisite) in the treatment of arsenic and mercury poisoning.
    J Am Med Assoc; 1946 Jul; 131():824. PubMed ID: 20987433
    [No Abstract]   [Full Text] [Related]  

  • 6. British anti-lewisite; dithiol compounds as antidotes for arsenic.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):535-48. PubMed ID: 20273639
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of acute gold and arsenic poisoning; use of BAL (2,3-dimercaptopropanol, British anti-lewisite).
    COHEN A; GOLDMAN J; DUBBS AW
    J Am Med Assoc; 1947 Mar; 133(11):749-52. PubMed ID: 20283984
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of experimental arsenic poisoning with the dithiols.
    RIKER WF
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):66-71. PubMed ID: 20275114
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical injury in arsenical intoxication and the British Anti-Lewisite].
    PETERS RA
    Rev Med Liege; 1948 Dec; 3(23):687-98. PubMed ID: 18100780
    [No Abstract]   [Full Text] [Related]  

  • 10. British anti-Lewisite. III. Developments and applications.
    PETERS RA
    J R Inst Public Health; 1952 Jun; 15(6):151-67. PubMed ID: 14939268
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 12. 2,3 Dithiolpropanol ("BAL") as a specific detoxifying agent for arsenic.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    Fed Proc; 1946; 5(1 Pt 2):175. PubMed ID: 21064305
    [No Abstract]   [Full Text] [Related]  

  • 13. British anti-Lewisite. II. Dithiols as antidotes.
    PETERS RA
    J R Inst Public Health; 1952 May; 15(5):122-39. PubMed ID: 14918251
    [No Abstract]   [Full Text] [Related]  

  • 14. Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
    HARRISON HE; ORDWAY NK
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):76-80. PubMed ID: 20275116
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
    HARRISON HE; DURLACHER SH
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):81-4. PubMed ID: 20275117
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of BAL on the excretion of arsenoxides.
    CHANCE AC; LEVVY GA
    Q J Exp Physiol Cogn Med Sci; 1947 Jan; 34(1):79-82. PubMed ID: 20288860
    [No Abstract]   [Full Text] [Related]  

  • 19. British anti-lewisite; its use and therapeutic value in arsenical intoxications.
    PETERS RA; BENNET J
    Lancet; 1947 Oct; 2(6475):497. PubMed ID: 20265166
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management.
    CORMIA FE; BLAUNER SG
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.